Endocrine Abstracts

Objectives: 1) To determine the prevalence on the main comorbidities in morbid obese patients; 2) To analize the bariatric surgery effects on the comorbidities; and 3) To evaluate the complications of bariatric surgery

Methods: Cohort study with intrasubject measures (before-after) in a sample of 333 patients with morbid obesity who underwent bariatric surgery (bypass gastric or sleeve gastrectomy) in Puerta del Mar Hospital (Cádiz, Spain) between 2005 and 2015. Demographic characteristics, anthropometric parameters, cardiovascular risk factors and surgical complications were analyzed baseline and two years after surgery.

Results: A total of 333 patients were included (71.5% female), with mean age 40.05±9.98 years. The mean preoperative BMI was 50.21±6.98 kg/m². Before surgery 26.45% were smokers, 42.3% had hypertension, 45% dyslipidemia and 26.3% diabetes. 5.1% of patients underwent bypass gastric and 44.9% sleeve gastrectomy. After 2 years of follow up, the percentage of weight lost was 69.16%. Remission of hypertension, dyslipidemia and diabetes mellitus type 2 had occurred in 68.4%, 75.5% and 77.6% respectively (P<0.001). Levels of HbA1c, cholesterol and trygliceridemia were reduced significantly after surgery. 12% of patients had early complications and 17.5% developed later complications (The most frequent complication was eventration).

Conclusions: Bariatric surgery in our area is an effective tool in weight loss. It is related with early beneficial effects on metabolic disorders and have similar rate of surgical complications compared with other series.